Uncategorized
Valeant announces CEO succession plan, financial update
Valeant Pharmaceuticals International announced in a press released that it has initiated a search for a new CEO to succeed J. Michael Pearson and has made changes to its board of directors.Pearson will continue to serve as CEO and a director until a replacement is appointed, according to the release.